Domov › Srpastocelična anemija › Maryland
Klinične študije za Srpastocelična anemija v Maryland
17 študij za Srpastocelična anemija išče udeležence na lokacijah v Maryland.
Mesta v Maryland
Uradno besedilo študije (angleško)
Collection of Human Biospecimens for Basic and Clinical Research Into Globin Variants
- National Institutes of Health Clinical Center, Bethesda
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
Starost 18–70 · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT03937817Blood Sampling for Research Related to Sickle Cell Disease
- National Institutes of Health Clinical Center, Bethesda
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
Starost 18–100 · Vsi spoli · Posodobljeno 29. sep. 2026 · NCT00542230Determination of Red Cell Survival in Sickle Cell Disease and Other Hemoglobinopathies Using Biotin Labeling
- National Institutes of Health Clinical Center, Bethesda
Vključevanje udeležencevZgodnja faza 1
Starost 18–100 · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT06313398A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
- The Johns Hopkins University School of Medicine, Baltimore
Vključevanje udeležencevFaza 3
Starost 12–100 · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT06439082Dietary Intake and Dietary Behaviors in Adults With Sickle Cell Disease
- National Institutes of Health Clinical Center, Bethesda
Vključevanje udeležencevOpazovalna študija
Starost 18–120 · Vsi spoli · Posodobljeno 18. sep. 2026 · NCT05170412Study to Evaluate the Safety and Tolerability of Escalating Doses of Fostamatinib in Subjects With Stable Sickle Cell Disease
- National Institutes of Health Clinical Center, Bethesda
Vključevanje udeležencevFaza 1
Starost 18–65 · Vsi spoli · Posodobljeno 17. sep. 2026 · NCT05904093Study to Understand the Genetic Risk of Developing an Immune Response After Blood Transfusions Among Individuals With Sickle Cell Disease
- National Institutes of Health Clinical Center, Bethesda
Vključevanje udeležencevOpazovalna študija
Starost 2–99 · Vsi spoli · Posodobljeno 11. sep. 2026 · NCT06944067SCD Stem Cell Mobilization and Apheresis Using Motixafortide
- National Heart, Blood and Lung Institute-Cellular and Molecular Therapy Branch, Bethesda
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 8. sep. 2026 · NCT06442761Partial Stem Cell Transplant for Sickle Cell Disease From Matched Donors
- National Institutes of Health Clinical Center, Bethesda
Vključevanje udeležencevFaza 1/2
Starost 4–65 · Vsi spoli · Posodobljeno 4. sep. 2026 · NCT07599176Escalating Doses of VAS-101 in Subjects With Stable Sickle Cell Disease
- National Institutes of Health Clinical Center, Bethesda
Vključevanje udeležencevFaza 1
Starost 18–90 · Vsi spoli · Posodobljeno 24. avg. 2026 · NCT07566494A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease
- Local Institution - 0064, Baltimore
Vključevanje udeležencevFaza 1/2Vabljeni zdravi prostovoljci
Starost 18 in več · Vsi spoli · Posodobljeno 18. avg. 2026 · NCT06481306ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- Johns Hopkins University Hemophilia Treatment Center, Baltimore
Vključevanje udeležencevOpazovalna študija
Vse starosti · Vsi spoli · Posodobljeno 17. avg. 2026 · NCT04398628Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
- University of Maryland, Baltimore
Vključevanje udeležencevFaza 2
Starost 12 in več · Vsi spoli · Posodobljeno 14. avg. 2026 · NCT06699849Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)
- Center for Cancer and Blood Disorders, Bethesda
Vključevanje udeležencevFaza 2
Starost 18 in več · Vsi spoli · Posodobljeno 5. avg. 2026 · NCT07224360The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease
- University of Maryland School of Medicine - Baltimore- Site Number : 8400041, Baltimore
Vključevanje udeležencevFaza 3
Starost 10–65 · Vsi spoli · Posodobljeno 29. jul. 2026 · NCT06975865Cooperative Assessment of Late Effects for SCD Curative Therapies
- Johns Hopkins Hospital, Baltimore
- National Institutes of Health Clinical Center, Bethesda
Vključevanje udeležencevOpazovalna študija
Starost 4–65 · Vsi spoli · Posodobljeno 27. jul. 2026 · NCT05153967Virtual Reality Devices as an Adjunct to Usual Care for Patients With Sickle Cell Disease Experiencing Vaso-Occlusive Crises
- University of Maryland Medical Systems, Baltimore
Vključevanje udeležencev
Starost 18 in več · Vsi spoli · Posodobljeno 24. dec. 2025 · NCT06184126Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.